[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4910 Introduced in House (IH)]

<DOC>






118th CONGRESS
  1st Session
                                H. R. 4910

To amend section 230 of the Communications Act of 1934 to provide that 
   such section has no effect on certain laws relating to controlled 
             substances and drugs, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             July 26, 2023

 Mr. Guthrie introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
To amend section 230 of the Communications Act of 1934 to provide that 
   such section has no effect on certain laws relating to controlled 
             substances and drugs, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Deplatform Drug Dealers Act''.

SEC. 2. NO EFFECT ON CERTAIN LAWS RELATING TO CONTROLLED SUBSTANCES AND 
              DRUGS.

    Section 230(e) of the Communications Act of 1934 (47 U.S.C. 230(e)) 
is amended by adding at the end the following:
            ``(6) No effect on certain laws relating to controlled 
        substances and drugs.--In addition to the exception provided by 
        paragraph (1) for Federal criminal statutes, nothing in this 
        section (other than subsection (c)(2)(A)) shall be construed to 
        impair or limit any action for civil penalties, damages, or 
        equitable relief based on advertising or offering to sell, 
        deliver, distribute, dispense, or introduce into interstate 
        commerce a controlled substance (as defined in section 102 of 
        the Controlled Substances Act (21 U.S.C. 802)) or drug (as 
        defined in section 201 of the Federal Food, Drug, and Cosmetic 
        Act (21 U.S.C. 321)) in violation of--
                    ``(A) section 401(h) or 403(c)(2) of the Controlled 
                Substances Act (21 U.S.C. 841(h); 843(c)(2)); or
                    ``(B) section 301(a), 301(d), or 505(a) of the 
                Federal Food, Drug, and Cosmetic Act (21 U.S.C. 331(a); 
                331(d); 355(a)).''.
                                 <all>